Evidence map›Paper›PMID 32997707›Full record

ArticlePLoS pathogens2020

Insertion and deletion evolution reflects antibiotics selection pressure in a Mycobacterium tuberculosis outbreak.

Maxime Godfroid, Tal Dagan, Matthias Merker, Thomas A Kohl, Roland Diel, Florian P Maurer, Stefan Niemann, Anne Kupczok

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. ClinicalFrontiers in microbiology · 2025
    Pooled it
  2. Article
  3. Molecular Tracing and Comparative Genomics Analysis ofPathogens (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugs.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Large-scale Pan Genomic Analysis ofEvolutionary bioinformatics online · 2024
    Article
  12. Article
  13. Article
  14. Journal of clinical microbiology · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. A critical evaluation ofMicrobial genomics · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Maxime GodfroidInstitute of General Microbiology, Kiel University, Kiel, Germany.ORCID 0000-0001-9037-4265
Tal DaganInstitute of General Microbiology, Kiel University, Kiel, Germany.ORCID 0000-0002-9042-192X
Matthias MerkerMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Thomas A KohlMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.ORCID 0000-0002-1126-6803
Roland DielGerman Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.ORCID 0000-0001-8304-7709
Florian P MaurerNational and WHO Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany.ORCID 0000-0001-8353-5964
Stefan NiemannMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
Anne KupczokInstitute of General Microbiology, Kiel University, Kiel, Germany.ORCID 0000-0001-5237-1899
Christian-Albrechts-Universität zu Kiel · DEGerman Center for Infection Research · DEUniversität Hamburg · DEUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In genome evolution, genetic variants are the source of diversity, which natural selection acts upon. Treatment of human tuberculosis (TB) induces a strong selection pressure for the emergence of antibiotic resistance-conferring variants in the infecting Mycobacterium tuberculosis (MTB) strains. MTB evolution in response to treatment has been intensively studied and mainly attributed to point substitutions. However, the frequency and contribution of insertions and deletions (indels) to MTB genome evolution remains poorly understood. Here, we analyzed a multi-drug resistant MTB outbreak for the presence of high-quality indels and substitutions. We find that indels are significantly enriched in genes conferring antibiotic resistance. Furthermore, we show that indels are inherited during the outbreak and follow a molecular clock with an evolutionary rate of 5.37e-9 indels/site/year, which is 23 times lower than the substitution rate. Inherited indels may co-occur with substitutions in genes along related biological pathways; examples are iron storage and resistance to second-line antibiotics. This suggests that epistatic interactions between indels and substitutions affect antibiotic resistance and compensatory evolution in MTB.

Indexed as

Evolution, MolecularAnti-Bacterial AgentsAntitubercular AgentsDisease OutbreaksGenomeHumansMycobacterium tuberculosisSelection, GeneticTuberculosisAnti-Bacterial AgentsAntitubercular Agents

Identifiers

PMID32997707
PMCPMC7549793
OpenAlexW3090128501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.